GEN Exclusives

More »

GEN News Highlights

More »
Feb 2, 2007

Bavarian Nordic and GSK Terminate Partnership on Smallpox Vaccine

  • Bavarian Nordic agreed with GlaxoSmithKline not to pursue a collaboration for the production and marketing of Imvamune®, a third-generation smallpox vaccine under development.

    The companies had previously signed a memorandum to ensure sufficient production capacity from several facilities and distribution of imvamune to various international markets at a time where Bavarian Nordic’s production facility was not established. Now Bavarian Nordic says it has the capacity to produce the expected RFP-III order.


GEN Jobs powered by connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
More »

Be sure to take the GEN Poll

Disclosing Clinical Trial Data

Do you believe that conducting performance audits for new drugs will incentivize pharma firms to become more transparent?

More »